A61K39/0005 - page 3 - CPC Classification Index

#601

20150152172

2015-06-04

COMPOSITIONS AND METHODS FOR BINDING CYSTEINYL LEUKOTRIENES (CYSLTS) FOR TREATMENT OF DISEASE

#602

20150150956

2015-06-04

EPITOPE COMPOSITION

#603

20150147388

2015-05-28

Materials and methods for modulating immune responses

#604

20150140065

2015-05-21

Method for inducing an immune response and formulations thereof

#605

20150140034

2015-05-21

Oil-based adjuvants

#606

20150140028

2015-05-21

Recombinant bacterium and uses thereof

#607

20150139937

2015-05-21

Methods and compositions for inhibiting diseases of the central nervous system

#608

20150132340

2015-05-14

Cationic lipid vaccine compositions and methods of use

#609

20150132302

2015-05-14

Vaccine and uses thereof

#610

20150125384

2015-05-07

Modular nanodevices for smart adaptable vaccines

#611

20150118750

2015-04-30

Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof

#612

20150118256

2015-04-30

IgE CH3 peptide vaccine

#613

20150110832

2015-04-23

Deletion mutants of flagellin and methods of use

#614

20150110805

2015-04-23

THERAPEUTIC STRATEGY FOR TREATING AUTOIMMUNE AND DEGENERATIVE DISEASES

#615

20150110802

2015-04-23

ANTIBODY PRODUCTION METHODS

#616

20150104474

2015-04-16

Methods of inhibiting gonad maturation

#617

20150099859

2015-04-09

Deletion mutants of flagellin and methods of use

#618

20150098957

2015-04-09

PCSK9 vaccine

#619

20150098953

2015-04-09

Methods of treating a patient having an autoimmune disorder by administering a soluble BCMA

#620

20150093406

2015-04-02

Modified coiled coil type proteins having improved properties

#621

20150086593

2015-03-26

Allergy inhibitor compositions and kits and methods of using the same

#622

20150071951

2015-03-12

PCSK9 peptide combination vaccine and method of use

#623

20150050297

2015-02-19

Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant

#624

20150024006

2015-01-22

Allogeneic cellular immunotherapy for opportunistic infection

#625

20150023967

2015-01-22

Binding molecules for BCMA and CD3

#626

20150010631

2015-01-08

Immune-modifying nanoparticles for the treatment of inflammatory diseases

#627

20150010495

2015-01-08

Method for the production of an immunostimulating mucin (MUC1)

#628

20150004218

2015-01-01

Compositions and methods for immune tolerance induction

#629

20150004188

2015-01-01

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

#630

20150004187

2015-01-01

Method for prevention of colectomy

#631

20150004184

2015-01-01

Elastin digest compositions and methods utilizing same

#632

20150004161

2015-01-01

Fc Coupled Compositions and Methods of Their Use

#633

20140378665

2014-12-25

Growth differentiation factor 15 (GDF-15) polypeptides

#634

20140369956

2014-12-18

Conjugates of GM-CSF and IL-7, compositions and methods related thereto

#635

20140363446

2014-12-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#636

20140356380

2014-12-04

Neutralizing antibodies and methods of use thereof

#637

20140348846

2014-11-27

Anti-HLA class-IB antibodies mimic immunoreactivity and immunomodulatory functions of intravenous immunoglobulin (IVIG) useful as therapeutic IVIG mimetics and methods of their use

#638

20140348837

2014-11-27

Binding molecules for BCMA and CD3

#639

20140348822

2014-11-27

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

#640

20140341974

2014-11-20

Liposomal vaccine adjuvants and methods of making and using same

#641

20140328924

2014-11-06

Methods of administering immunosuppressants having a specified pharmacodynamic effective life and therapeutic macromolecules for the induction of immune tolerance

#642

20140328922

2014-11-06

Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity

#643

20140328921

2014-11-06

Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen

#644

20140328865

2014-11-06

Immune modulation via C-type lectin

#645

20140328854

2014-11-06

Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose

#646

20140322161

2014-10-30

Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6

#647

20140314839

2014-10-23

Controlled-release peptide compositions and uses thereof

#648

20140314837

2014-10-23

Vaccine Therapy

#649

20140308300

2014-10-16

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

#650

20140301945

2014-10-09

Human anti-SOD1 antibodies

#651

20140294781

2014-10-02

Method to formulate T-cells

#652

20140294731

2014-10-02

Phosphospecific antibodies recognising tau

#653

20140286999

2014-09-25

Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties

#654

20140271815

2014-09-18

HEAT-AND FREEZE-STABLE VACCINES AND METHODS OF MAKING AND USING SAME

#655

20140271725

2014-09-18

Small molecule enhancer for dendritic cell cancer vaccines

#656

20140255437

2014-09-11

TOPK peptides and vaccines including the same

#657

20140255411

2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#658

20140255389

2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#659

20140248302

2014-09-04

Recombinant proteins and their therapeutic uses

#660

20140248301

2014-09-04

Method of inducing the production of protective anti-HIV-1 antibodies

#661

20140242101

2014-08-28

PD-L1 based immunotherapy

#662

20140227301

2014-08-14

Immunogenic compositions against human progastrin peptides

#663

20140227286

2014-08-14

Annexin A2 as immunological target

#664

20140221609

2014-08-07

Activation of sodium potassium ATPase

#665

20140220100

2014-08-07

VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION

#666

20140220056

2014-08-07

VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION

#667

20140220051

2014-08-07

Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling activity with soluble light polypeptide sequences

#668

20140220038

2014-08-07

LRP1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (VLDL) to ischaemic cardiac muscle

#669

20140220011

2014-08-07

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#670

20140212441

2014-07-31

PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES, ALLERGIC DISEASES AND AUTOIMMUNE DISEASES

#671

20140205653

2014-07-24

Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use

#672

20140199340

2014-07-17

Tolerogenic synthetic nanocarriers for inducing regulatory B cells

#673

20140193441

2014-07-10

Method of Administering Porcine B-domainless fVIII

#674

20140193385

2014-07-10

Method for stimulating a host immune system

#675

20140186371

2014-07-03

COMPOSITIONS AND METHODS FOR TREATING DISEASES OF PROTEIN AGGREGATION INVOLVING IC3B DEPOSITION

#676

20140178474

2014-06-26

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

#677

20140170169

2014-06-19

BLOCKING ANTIBODY FOR TRANSPLANTATION

#678

20140154278

2014-06-05

Method for allogeneic cell therapy

#679

20140154274

2014-06-05

METHODS AND COMPOSITIONS FOR USE IN INTRALYMPHATIC CELLULAR THERAPIES

#680

20140147456

2014-05-29

CETP fragments

#681

20140134195

2014-05-15

BETA-2 MICROGLOBULIN-DEFICIENT CELLS

#682

20140127268

2014-05-08

Method for expanding monocytes

#683

20140127244

2014-05-08

Vaccines for suppressing IgE-mediated allergic disease and methods for using the same

#684

20140120124

2014-05-01

Cell capable of expressing exogenous GITR ligand

#685

20140112941

2014-04-24

Mammalian receptors as targets for antibody and active vaccination therapy against mold infections

#686

20140112883

2014-04-24

METHODS FOR REDUCING AN ADVERSE IMMUNE RESPONSE TO A FOREIGN ANTIGEN IN A HUMAN SUBJECT WITH ANTI-CD4 ANTIBODIES OR CD4-BINDING FRAGMENTS THEREOF OR CD4-BINDING MOLECULES

#687

20140105906

2014-04-17

Peptide for protection of allergic respiratory disorders

#688

20140099335

2014-04-10

DNA vaccine

#689

20140072593

2014-03-13

Method for suppressing an immune response

#690

20140065184

2014-03-06

HLA-G isoform for use in the treatment of a disease associated with bone resorption

#691

20140056936

2014-02-27

Compositions and methods using recombinant MHC molecules for the treatment of stroke

#692

20140044734

2014-02-13

Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitis

#693

20140004148

2014-01-02

Methods and compositions for inhibiting diseases of the central nervous system

#694

20140004079

2014-01-02

IN VIVO DENDRITIC CELL THERAPEUTIC ADJUVANT

#695

20130345407

2013-12-26

Method of producing a positive inotropic effect using an antibody that binds sodium potassium atpase

#696

20130336999

2013-12-19

PEPTIDE WITH REDUCED DIMER FORMATION

#697

20130330411

2013-12-12

Pharmaceutical cyclosporin compositions

#698

20130302278

2013-11-14

USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS

#699

20130295129

2013-11-07

Immunostimulatory compositions and methods of use thereof

#700

20130287717

2013-10-31

Method for improving skin appearance and reducing hair loss

#701

20130273120

2013-10-17

Methods and compositions for intranasal delivery

#702

20130273086

2013-10-17

Compositions and methods for treatment, research and therapeutic applications for malaria

#703

20130266598

2013-10-10

Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For Immunotherapy

#704

20130230487

2013-09-05

Immunomodulatory methods and systems for treatment and/or prevention of hypertension

#705

20130224238

2013-08-29

Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors

#706

20130216565

2013-08-22

Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein

#707

20130202584

2013-08-08

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

#708

20130189292

2013-07-25

Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions

#709

20130189289

2013-07-25

Vaccine for treatment of tautopathy

#710

20130177625

2013-07-11

Immunogenic compositions and methods for treating neoplasia

#711

20130156770

2013-06-20

Binding molecules for BCMA and CD3

#712

20130156769

2013-06-20

Binding molecules for BCMA and CD3

#713

20130156766

2013-06-20

TREATMENT OF DRY AGE RELATED MACULAR DEGENERATION

#714

20130136737

2013-05-30

Uses of NOGO-A inhibitors and related methods

#715

20130129781

2013-05-23

Methods and compositions for intranasal delivery

#716

20130109057

2013-05-02

Method for immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma, and method for producing monoclonal antibody

#717

20130108656

2013-05-02

Peptide for reducing the phosphate requirement and excretion from farm animals

#718

20130078268

2013-03-28

VACCINE COMPOSITIONS AND METHODS OF USE THEREOF

#719

20130064841

2013-03-14

Immunogenic compositions against human progastrin peptides

#720

20130052212

2013-02-28

Allogeneic cell compositions with cross-linked CD3/CD28

#721

20130039934

2013-02-14

Treatment of IgE-mediated disease

#722

20130022630

2013-01-24

Method for treating amyloid disease

#723

20130011431

2013-01-10

Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant

#724

20120328605

2012-12-27

COMPOSITIONS AND USES

#725

20120321699

2012-12-20

METHOD OF INDUCING THE PRODUCTION OF PROTECTIVE ANTI-HIV-1 ANTIBODIES

#726

20120321694

2012-12-20

COMPOSITIONS AND USES

#727

20120321664

2012-12-20

Modulation of yeast-based immunotherapy products and responses

#728

20120294888

2012-11-22

Tolerogenic synthetic nanocarriers for allergy therapy

#729

20120282292

2012-11-08

Methods and compositions related to immunogenic fibrils

#730

20120276159

2012-11-01

Tolerogenic synthetic nanocarriers

#731

20120276158

2012-11-01

Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses

#732

20120276127

2012-11-01

Treatment of retinal disorders with recombinant T cell receptor ligand (RTL)

#733

20120276109

2012-11-01

Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins

#734

20120276009

2012-11-01

Pharmaceutical composition

#735

20120270788

2012-10-25

Method of administering porcine B-domainless fVIII

#736

20120269834

2012-10-25

IMMUNOGLOBULIN CLEAVAGE FRAGMENT VACCINE COMPOSITIONS

#737

20120263747

2012-10-18

Albumin-Fused Anti-Angiogenesis Peptides

#738

20120263728

2012-10-18

Method to generate antibodies to ion channels

#739

20120263677

2012-10-18

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

#740

20120258167

2012-10-11

Oral pharmaceutical composition

#741

20120258041

2012-10-11

COMPOSITIONS AND METHODS FOR TREATING DISEASES OF PROTEIN AGGREGATION INVOLVING IC3B DEPOSITION

#742

20120231030

2012-09-13

Multi-epitopic vaccine

#743

20120207820

2012-08-16

Composition for treatment of multiple sclerosis

#744

20120183599

2012-07-19

Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines

#745

20120183597

2012-07-19

Method of inducing neutralizing antibodies to human immunodeficiency virus

#746

20120171233

2012-07-05

Peptide inhibitors for mediating stress responses

#747

20120156233

2012-06-21

Methods for treating a disease caused by choroidal neovascularization

#748

20120156135

2012-06-21

Particles with multiple functionalized surface domains

#749

20120148606

2012-06-14

Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof

#750

20120148605

2012-06-14

Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4T cell response to APOB100

#751

20120142585

2012-06-07

Leptin antagonist and methods of use

#752

20120135022

2012-05-31

Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3

#753

20120134997

2012-05-31

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#754

20120129770

2012-05-24

NOVEL POLYNUCLEOTIDE MOLECULES FOR ENHANCED GENE EXPRESSION

#755

20120122207

2012-05-17

Method for expanding monocytes

#756

20120121595

2012-05-17

FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS

#757

20120114674

2012-05-10

Molecular Antigen Array

#758

20120076806

2012-03-29

Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof

#759

20120039994

2012-02-16

Treatment of allergic conditions using a composition containing synthetic adjuvant

#760

20120039931

2012-02-16

DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof

#761

20120027806

2012-02-02

Dose selection of adjuvanted synthetic nanocarriers

#762

20120027803

2012-02-02

Biodegradable lipids for the delivery of active agents

#763

20120020956

2012-01-26

Antibodies that bind alpha subunit of sodium potassium ATPase

#764

20120003267

2012-01-05

Therapeutic Agents

#765

20110311536

2011-12-22

PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE

#766

20110306756

2011-12-15

Prevention and Treatment of Amyloidogenic Disease

#767

20110305723

2011-12-15

Molecular Antigen Array

#768

20110305701

2011-12-15

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

#769

20110300163

2011-12-08

IgE CH3 peptide vaccine

#770

20110293723

2011-12-01

SYNTHETIC NANOCARRIER COMBINATION VACCINES

#771

20110293701

2011-12-01

MULTIVALENT SYNTHETIC NANOCARRIER VACCINES

#772

20110293700

2011-12-01

NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT

#773

20110293616

2011-12-01

Antigen-presenting complex-binding compositions and uses thereof

#774

20110293608

2011-12-01

ANNEXIN A2 AS IMMUNOLOGICAL TARGET

#775

20110274709

2011-11-10

T-cell immunogens derived from anti-viral proteins and methods of using same

#776

20110274707

2011-11-10

Composition for improving inflammatory disease using ABH antigens

#777

20110262894

2011-10-27

VACCINE AGAINST INFECTIOUS AGENTS HAVING AN INTRACELLULAR PHASE, COMPOSITION FOR THE TREATMENT AND PREVENTION OF HIV INFECTIONS, ANTIBODIES AND METHODS OF DIAGNOSIS

#778

20110262526

2011-10-27

METHOD OF INDUCING AN ANTI-VIRAL IMMUNE RESPONSE

#779

20110256163

2011-10-20

Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy

#780

20110250230

2011-10-13

Cell capable of expressing exogenous GITR ligand

#781

20110250174

2011-10-13

Stable immunogenic product comprising antigenic heterocomplexes

#782

20110243975

2011-10-06

Transformed soybean plant which accumulates vaccine, and use thereof

#783

20110236429

2011-09-29

Small cationic antimicrobial peptides

#784

20110229529

2011-09-22

Lipid vesicle compositions and methods of use

#785

20110217308

2011-09-08

Compositions and methods using recombinant MHC molecules for the treatment of stroke

#786

20110212119

2011-09-01

METHODS FOR MAKING HIV VACCINES AND RELATED COMPOSITIONS

#787

20110212097

2011-09-01

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

#788

20110206708

2011-08-25

Method for stimulating a therapeutic immune effect in a patient

#789

20110206707

2011-08-25

Method for stimulating a host immune system

#790

20110195080

2011-08-11

Methods for enhanced somatostatin immunogenicity in the treatment of obesity

#791

20110182922

2011-07-28

Immunogenic compounds comprising peptides of IL1β

#792

20110182847

2011-07-28

USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS

#793

20110178024

2011-07-21

AMYLOID BETA-PEPTIDES AND METHODS OF USE THEREOF

#794

20110177109

2011-07-21

ANTIGENIC TAU PEPTIDES AND USES THEREOF

#795

20110135685

2011-06-09

Edible vaccines expressed in soybeans

#796

20110135680

2011-06-09

Deletion mutants of flagellin and methods of use

#797

20110123620

2011-05-26

Silicon dioxide nanoparticles and the use thereof for vaccination

#798

20110123558

2011-05-26

Peptide with reduced dimer formation

#799

20110123551

2011-05-26

HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use

#800

20110110964

2011-05-12

Immunogenic peptides and their use in transplantation

#801

20110110950

2011-05-12

Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BCMA

#802

20110097337

2011-04-28

Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells

#803

20110081371

2011-04-07

Angiotensin peptide-carrier conjugates and uses thereof

#804

20110076323

2011-03-31

Vaccine for alzheimer's disease

#805

20110070290

2011-03-24

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

#806

20110064795

2011-03-17

Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers

#807

20110059162

2011-03-10

Tannin-chitosan composites

#808

20110059111

2011-03-10

MAMMALIAN RECEPTORS AS TARGETS FOR ANTIBODY AND ACTIVE VACCINATION THERAPY AGAINST MOLD INFECTIONS

#809

20110052621

2011-03-03

PCSK9 vaccine

#810

20110052564

2011-03-03

ENHANCEMENT OF IMMUNOGENICITY OF ANTIGENS

#811

20110046042

2011-02-24

Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof

#812

20110044939

2011-02-24

REGULATORY T CELLS IN ADIPOSE TISSUE

#813

20110040259

2011-02-17

T-cell compositions that elicit type I cytokine response

#814

20110033478

2011-02-10

Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof

#815

20110033435

2011-02-10

Composition of activated CD4 cells

#816

20110028912

2011-02-03

Method to formulate T-cells

#817

20110014274

2011-01-20

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

#818

20110014194

2011-01-20

Methods for inhibiting angiogenesis using EGFL8 antagonists

#819

20110008382

2011-01-13

Compositions and methods using recombinant MHC molecules for the treatment of uveitis

#820

20100330088

2010-12-30

STRATEGIES TO PREVENT AND/OR TREAT IMMUNIE RESPONSES TO SOLUBLE ALLOFACTORS

#821

20100330070

2010-12-30

Methods Of Making An Antibody And Compositions Thereof

#822

20100330001

2010-12-30

Antibacterial compositions

#823

20100329983

2010-12-30

COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY

#824

20100322966

2010-12-23

Method for allogeneic cell therapy

#825

20100316564

2010-12-16

Immunological targeting of pathological Tau proteins

#826

20100313284

2010-12-09

MEANS AND METHODS FOR ELICITING AN IMMUNE RESPONSE

#827

20100304483

2010-12-02

T-CELL VACCINATION IN THE TREATMENT OF HIV INFECTION

#828

20100303836

2010-12-02

Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent

#829

20100298239

2010-11-25

Peptide with multiple epitopes

#830

20100297221

2010-11-25

Pharmaceutical composition of tacrolimus

#831

20100291105

2010-11-18

AGENT FOR THE TREATMENT OF MALIGNANT DISEASES

#832

20100278919

2010-11-04

Dendritic cell targeting compositions and uses thereof

#833

20100273992

2010-10-28

Method for the production of an immunostimulating mucin (MUC1)

#834

20100266619

2010-10-21

Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof

#835

20100260805

2010-10-14

Peptide for vaccine

#836

20100255087

2010-10-07

Oral pharmaceutical composition

#837

20100254994

2010-10-07

Isolated monoclonal antibody or antigen-binding fragment that cleaves octanoylated native ghrelin

#838

20100239599

2010-09-23

Vaccine peptide combinations against cat allergy

#839

20100221265

2010-09-02

Immune modulation via C-type lectin

#840

20100203120

2010-08-12

Pharmaceutical cyclosporin compositions

#841

20100183645

2010-07-22

ACTIVE OR PASSIVE IMMUNIZATION AGAINST PROAPOPTOTIC NEUROTROPHINS FOR THE TREATMENT AND/OR PREVENTION OF NEURODEGENERATIVE DISEASES

#842

20100167265

2010-07-01

VACCINE AGAINST INFECTIOUS AGENTS HAVING AN INTRACELLULAR PHASE, COMPOSITION FOR THE TREATMENT AND PREVENTION OF HIV INFECTIONS, ANTIBODIES AND METHOD OF DIAGNOSIS

#843

20100136037

2010-06-03

Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof

#844

20100136023

2010-06-03

THERAPEUTIC AGENTS

#845

20100129389

2010-05-27

METHODS OF MODULATING HVEM, BTLA AND CD160 CIS COMPLEX RESPONSE OR SIGNALING ACTIVITY WITH SOLUBLE LIGHT POLYPEPTIDE SEQUENCES

#846

20100111995

2010-05-06

Antigen conjugates and uses thereof

#847

20100092523

2010-04-15

Molecules and methods for treatment and detection of cancer

#848

20100092508

2010-04-15

Molecular Antigen Arrays

#849

20100080805

2010-04-01

Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof

#850

20100047265

2010-02-25

Active antiangiogenic therapy

#851

20100040574

2010-02-18

TREATMENT OF CANCER WITH ANTI-IL-1alpha ANTIBODIES

#852

20100034842

2010-02-11

Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease

#853

20100028415

2010-02-04

Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus

#854

20100028320

2010-02-04

Methods and compositions for inhibiting diseases of the central nervous system

#855

20100021500

2010-01-28

Processes for treating subjects carrying viral infectious agent

#856

20100021487

2010-01-28

Vaccines and methods for controlling adiposity

#857

20100010075

2010-01-14

Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated

#858

20100003272

2010-01-07

Method for expanding monocytes

#859

20090324629

2009-12-31

Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof

#860

20090297511

2009-12-03

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#861

20090281044

2009-11-12

Elastin digest compositions and methods utilizing same

#862

20090274647

2009-11-05

Immunotherapeutic Formulations with Interleukin-2-Neutralizing Capacity

#863

20090270329

2009-10-29

Methods of administering porcine B-domainless fVIII

#864

20090253778

2009-10-08

DNA composition against tumor stromal antigen FAP and methods of use thereof

#865

20090226489

2009-09-10

Viral vaccine composition, process and methods of use

#866

20090220551

2009-09-03

Concurrent chemotherapy and immunotherapy

#867

20090191149

2009-07-30

IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS

#868

20090181078

2009-07-16

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

#869

20090175893

2009-07-09

Albumin-Fused Anti-Angiogenesis Peptides

#870

20090155302

2009-06-18

Antigen Arrays for Treatment of Allergic Eosinophilic Diseases

#871

20090142377

2009-06-04

Immunogenic compositions

#872

20090136529

2009-05-28

Compositions and methods for treatment, research and therapeutic applications for malaria

#873

20090123414

2009-05-14

Il-15 Antigen Arrays And Uses Thereof

#874

20090093405

2009-04-09

Non-Natural Amino Acid Polypeptides Having Modified Immunogenicity

#875

20090060948

2009-03-05

Cationic lipid-mediated enhancement of nucleic acid immunization of cats

#876

20090041761

2009-02-12

Method of immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma and method for producing monoclonal antibody

#877

20090028847

2009-01-29

MULTIPLE MYELOMA AND AL AMYLOID IMMUNOTHERAPY TARGETING IMMUNOGLOBULIN LIGHT CHAINS AND USES THEREOF

#878

20090004200

2009-01-01

Combination treatment of pancreatic cancer

#879

20080305108

2008-12-11

Isolated TNF-alpha peptide and pharmaceutical composition thereof

#880

20080292704

2008-11-27

Methods and compositions involving polymeric immunoglobulin fusion proteins

#881

20080279871

2008-11-13

Method for eliciting an immune response to human telomerase reverse transcriptase

#882

20080279861

2008-11-13

Method for stimulating a host immune system by administering an allogeneic cell material

#883

20080279836

2008-11-13

Method of preparing a treatment effective amount of allogeneic T-cells

#884

20080274131

2008-11-06

Molecular antigen arrary

#885

20080267983

2008-10-30

Peptide inhibitors for mediating stress responses

#886

20080260800

2008-10-23

Extracellular matrix cancer vaccine adjuvant

#887

20080254050

2008-10-16

Antiangiogenic active immunotherapy

#888

20080248022

2008-10-09

Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases

#889

20080247994

2008-10-09

DNA vaccine

#890

20080206251

2008-08-28

Methods and compositions to treat misfolded-SOD1 mediated diseases

#891

20080193473

2008-08-14

Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein

#892

20080187577

2008-08-07

Immunogenic compositions comprising progastrin and uses thereof

#893

20080171712

2008-07-17

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

#894

20080152620

2008-06-26

Canine thymic stromal lymphopoietin protein and uses thereof

#895

20080118514

2008-05-22

Neutralizing antibodies and methods of use thereof

#896

20080113929

2008-05-15

Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist

#897

20080112950

2008-05-15

Naturally occurring IgM antibodies that bind lymphocytes

#898

20080095789

2008-04-24

Vaccine

#899

20080095738

2008-04-24

VLP-antigen conjugates and their uses as vaccines

#900

20080031890

2008-02-07

Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies